Autophagy is a double-edged sword in the development of stroke pathology and can modulate the stroke process in different ways, but the exact mechanism of action is not yet clear. It is now generally accepted that moderate autophagy activation is neuroprotective, whereas excessive autophagy activation is detrimental. Therefore, a potential therapeutic avenue for stroke treatment is through rational and effective regulation of the autophagic process. With this in mind, Ace Therapeutics has established a complete and well-established workflow for the study of stroke drug development targeting autophagy.
In order to explore the important regulatory role of autophagy in stroke, we should screen a large number of autophagy modulators and then evaluate the role of autophagy modulators on the stroke process under different experimental conditions. Based on our ultra-large compound library, natural product library, and fragment library, we provide different screening platforms for autophagy modulators to meet your different needs.
After screening to obtain a large number of autophagy modulators, we explore the effects of these autophagy modulators on stroke. Because differences in the type of stroke model, the type of autophagy modulator, the duration of action of the autophagy modulator, and the dose of autophagy modulator used can have a large or even opposite effect on the pathological outcome of stroke, Ace Therapeutics has established a complete service to explore the pharmacological activity of autophagy on stroke.
Ace Therapeutics has various testing platforms, such as observation of autophagosomes by transmission electron microscopy, tracing of autophagy formation by GFP-LC3 fusion protein, and expression of related genes or proteins by ELISA, western blotting, and qPCR assays, to verify the pharmacological activity of autophagy modulators on stroke under various experimental conditions.
If you would like to learn more about our services, please feel free to contact us.
We are committed to accelerating progress in stroke research and drug development.